1617-90-9 Vincamine AKSci J10447
 
 
Loading Please Wait...
  J10447    
Vincamine
, >98% (HPLC)
 



IDENTITY
CAS Number:1617-90-9
MDL Number:MFCD00078054
MF:C21H26N2O3
MW:354.44
EINECS:16-576-3
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:>98% (HPLC)
Physical Form (at 20°C):Solid
Melting Point:232-233°C
Optical Rotation:+40 ~ +46° (c=1, pyridine)
Long-Term Storage:Store long-term in a cool, dry place
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Solubility:Soluble in CHCl3

REVIEW

 Vincamine is a monoterpenoid indole alkaloid found in the leaves of Vinca minor, comprising about 25-65% of the indole alkaloids found in Vinca minor by weight. It is also found in the species Catharanthus roseus. Vincamine is poorly soluble potent neuroprotector and cerebral vasodilator, used for the treatment for CNS disorders. The compound is a peripheral vasodilator that increases blood flow to the brain (sold under the trademark Oxybral SR) . Generic drugs containing vincamine exist in specific regions. Most common drug preparations are in the sustained release forms. Vincamine is often used as a nootropic or agent to combat the effects of aging (also called smart drugs, memory enhancers, neuro enhancers, cognitive enhancers, and intelligence enhancers,), or in conjunction with other nootropics (such as piracetam) for a variety of purposes. Vincamine has been shown to be a potent blockers of voltage-gated Na+ channels, a mechanism that may contribute at least in part to the pharmacological/therapeutic benefit of these drugs.

REFERENCES
[1]Vereczkey L. Pharmacokinetics and metabolism of vincamine and related compounds. Eur J Drug Metab Pharmacokinet. 1985 Apr-Jun;10(2):89-103.
[2] Spagnoli A, Tognoni G. 'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders. 1983 Jul;26(1):44-69.
[3] Erdo SA, Molnár P, Lakics V, Bence JZ, Tömösközi Z. Vincamine and vincanol are potent blockers of voltage-gated Na+ channels. Eur J Pharmacol. 1996 Oct 24;314(1-2):69-73.
[4] Fischhof PK, Möslinger-Gehmayr R, Herrmann WM, Friedmann A, Russmann DL, Therapeutic efficacy of vincamine in dementia. Neuropsychobiology. 1996;34(1):29-35.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Warning

Hazard Statements
H302

Precautionary Statements
P264; P270; P301+P312; P330; P501


Current as of May 10, 2024


Download SDS Request COA

All products are stocked and shipped from San Francisco Bay Area, California, USA.

⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.



CATEGORIES

 APIs and Bioactives > Alkaloids, Vasodilators


PubChem
  @PubMed